Who Paid My Doc
Lumoxiti
Biological Oncology
NDC 0310-4700-01
General payments
$130,613
Research payments
$2,224,750
Through program year 2025, $130,613 in general payments and $2,224,750 in research payments were reported against Lumoxiti (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $9,005 | 3 |
| 2024 | General | $65,197 | 29 |
| 2023 | General | $36,308 | 18 |
| 2023 | Research | $458,900 | 6 |
| 2022 | Research | $1,765,600 | 2 |
| 2021 | General | $20,104 | 9 |
| 2021 | Research | $250 | 1 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
59 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.